Clinical Trial Update: Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating epoetin alfa for anemia in cancer patients receiving non-platinum chemotherapy has completed. The study was sponsored by Johnson & John…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cancer
• Neoplasm

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia, Cancer | Phase 3 | Status: COMPLETED